Literature DB >> 7059673

Acute leukemia in idiopathic sideroblastic anemia: response to combination chemotherapy.

K K Hussein, Z Salem, S S Bottomley, R B Livingston.   

Abstract

Three patients with idiopathic sideroblastic anemia of variable duration developed acute leukemia. In two the leukemia was morphologically and histochemically myeloblastic, in one lymphoblastic. With combination chemotherapy remission was achieved in all three. The remission inductions were complicated by long periods of bone marrow suppression and the duration of remissions was brief (3, 2 and 3 months). Survival after diagnosis was 13, 10 and 9 mo, respectively. The ring sideroblast abnormality persisted during the leukemic and remission phases and transfusion requirements remained unaltered in the two patients with transfusion dependent anemia throughout their courses.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059673

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  RARS with fibrosis and del(20q) transformed into ALL.

Authors:  Sandra S Rohr; Luís Arthur Flores Pelloso; Aline dos Santos Borgo; João Garibaldi de Rezende; Maria Regina Regis Silva; Mihoko Yamamoto; Maria de Lourdes L F Chauffaille
Journal:  Med Oncol       Date:  2012-07-04       Impact factor: 3.064

Review 2.  Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literature.

Authors:  Norihide Sato; Tomonori Nakazato; Masahiro Kizaki; Yasuo Ikeda; Shinichiro Okamoto
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

3.  Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature.

Authors:  Ayed A Algarni; Mojtaba Akhtari; Kai Fu
Journal:  Case Rep Hematol       Date:  2012-03-29

4.  Acute pro-B-Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review.

Authors:  Zhi-Ping Guo; Yan-Hong Tan; Jian-Lan Li; Zhi-Fang Xu; Xiu-Hua Chen; Lian-Rong Xu
Journal:  Oncol Lett       Date:  2018-04-20       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.